Building upon existing clinical and experimental research, our hypothesis posits that DNAJC12 mutations result in diminished activity of aromatic amino hydroxylases, leading to hyperphenylalaninemia and reduced neurotransmitter levels, which consequently contribute to intellectual disability. The gene discussed is DNAJC12; the disease is Hyperphenylalaninemia.